$51.47

+2.46 (+5.02%)

Pre-Market: $51.40 (-0.07, -0.14%)

Weekly Expected Move ±6.6%

$43 $46 $49 $53 $56

NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 31 · $5.0B mcap · 96M float · 1.68% daily turnover · Short 63% of daily vol

Credit Risk of going bust: lower than 50% of companies Debt: 13.6% of company value Bonds: none of note held by US funds details ▾

If the stock fell to about $0.70 (down 99%), CRISPR Therapeutics AG would be worth roughly what it owes.
Total debt $783.7M against a stock market value of $4.98B.
Distance to default 5.14 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $293.1M (short-term plus half of long-term), stock volatility 57.2%; Altman Z'' 3.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE

31.9 / 100

NoneWeakNarrowWide

Primary source: Switching Costs · ROIC: -253.2% · 5Y Avg: 175.6%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CRSP has No discernible competitive edge (31.9/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. Negative ROIC of -253.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$52

Low

$54

Avg Target

$55

High

Based on 2 analysts since Aug 3, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 22Hold: 14Sell: 2Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$53.50

Analysts2

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-10-14	UBS	—	$80	$52	-28	+3.5%	$50.22
2026-08-06	Goldman Sachs	—	Initiated	$55	—	+5.3%	$52.22
2026-07-08	H.C. Wainwright	Mitchell Kapoor	$65	$80	+15	+31.6%	$60.77
2026-06-12	UBS	—	Initiated	$80	—	+59.3%	$50.23
2026-06-11	Morgan Stanley	Maxwell Skor	$33	$60	+27	+21.4%	$49.44
2026-05-13	Bernstein	—	Initiated	$56	—	+6.0%	$52.83
2026-05-11	Evercore ISI	—	$74	$76	+2	+36.8%	$55.56
2026-02-17	Morgan Stanley	—	Initiated	$33	—	-36.8%	$52.25
2026-02-14	Chardan Capital	Geulah Livshits	$74	$76	+2	+43.2%	$53.07
2026-02-13	Needham	—	$84	$82	-2	+52.1%	$53.89
2026-02-13	Evercore ISI	—	Initiated	$74	—	+37.5%	$53.80
2025-11-26	Chardan Capital	—	$79	$74	-5	+40.2%	$52.79
2025-11-11	RBC Capital	Luca Issi	$60	$50	-10	-8.4%	$54.58
2025-10-13	Wells Fargo	Yanan Zhu	$105	$75	-30	+2.6%	$73.09
2025-02-03	H.C. Wainwright	Mitchell Kapoor	Initiated	$65	—	+62.5%	$40.00
2024-11-06	Oppenheimer	Jay Olson	$172	$95	-77	+91.9%	$49.51
2024-11-05	Leerink Partners	Rick Bienkowski	$120	$67	-53	+33.0%	$50.36
2024-08-12	Truist Financial	Joon Lee	Initiated	$100	—	+114.8%	$46.55
2024-08-06	Needham	Gil Blum	$170	$84	-86	+67.6%	$50.11
2024-08-06	Stifel Nicolaus	Benjamin Burnett	Initiated	$59	—	+18.0%	$50.01
2024-08-06	RBC Capital	Luca Issi	Initiated	$60	—	+19.7%	$50.13
2024-05-09	Robert W. Baird	Jack Allen	Initiated	$52	—	-2.4%	$53.29
2022-11-23	Citigroup	—	Initiated	$63	—	+13.1%	$55.72
2022-08-09	Chardan Capital	Geulah Livshits	Initiated	$79	—	-2.6%	$81.39
2022-06-17	BMO Capital	Kostas Biliouris	Initiated	$98	—	+38.6%	$70.73
2022-04-28	Credit Suisse	—	Initiated	$78	—	+50.1%	$51.96
2022-02-15	Needham	Gil Blum	Initiated	$170	—	+174.3%	$61.97
2022-02-14	Leerink Partners	Rick Bienkowski	Initiated	$120	—	+96.8%	$60.97
2022-01-06	Wells Fargo	Yanan Zhu	Initiated	$105	—	+55.2%	$67.66
2021-11-03	Oppenheimer	Jay Olson	Initiated	$172	—	+84.9%	$93.00
2021-10-11	Piper Sandler	Edward Tenthoff	Initiated	$180	—	+75.5%	$102.59
2021-08-15	Canaccord Genuity	Arlinda Lee	Initiated	$160	—	+30.6%	$122.55
2021-06-10	Roth Capital	Anthony Butler	Initiated	$171	—	+34.6%	$127.00
2021-04-20	Jefferies	Maury Raycroft	Initiated	$172	—	+37.7%	$124.93

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CRSP receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (2/5).

Rating Change History

Date	From	To
2026-10-16	D+	C-
2026-10-01	C-	D+
2026-04-01	C	C-
2026-03-20	C-	C
2026-03-12	C	C-
2026-03-09	C-	C
2026-03-02	C	C-
2026-02-18	C+	C
2026-02-17	C	C+
2026-02-13	C-	C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 26 Grade D

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CRSP scores highest in Balance Sheet (80/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

2.78

Grey Zone

Piotroski F-Score

3/9

✗ ✗ ✓ ✓ ✗ ✓ ✗ ✗ ✗

Beneish M-Score

—

Ohlson O-Score

-7.87

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

BBB+

Score: 62.2/100

Trend: Deteriorating

Earnings Quality

—

OCF/NI: 0.82x

Accruals: -3.5%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CRSP scores 2.78, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CRSP scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CRSP's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CRSP receives an estimated rating of BBB+ (score: 62.2/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-10.81x

PEG

-2.41x

P/S

371.62x

P/B

2.84x

P/FCF

-14.08x

P/OCF

—

EV/EBITDA

-8.11x

EV/Revenue

275.04x

EV/EBIT

-7.79x

EV/FCF

-9.85x

Earnings Yield

-8.57%

FCF Yield

-7.10%

Shareholder Yield

0.00%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CRSP currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.007

NI / EBT

Interest Burden

0.948

EBT / EBIT

EBIT Margin

-35.298

EBIT / Rev

Asset Turnover

0.006

Rev / Assets

Equity Multiplier

1.354

Assets / Equity

ROE

-26.1%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CRSP's ROE of -26.1% is driven by Asset Turnover (0.006), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$51.47

Median 1Y

$43.38

5th Pctile

$15.87

95th Pctile

$118.69

Ann. Volatility

61.0%

Analyst Target

$53.50

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

-84.0% YoY

Revenue / Employee

$55,714

Rev: $3,510,000

Profit / Employee

$-9,231,730

NI: $-581,599,000

SGA / Employee

$1,167,333

Avg labor cost proxy

R&D / Employee

$4,211,540

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	21.4%	18.6%	15.4%	-27.0%	-30.5%	-30.4%	-25.6%	-21.3%	-19.2%	-8.2%	-11.0%	-14.0%	-13.1%	-19.2%	-19.7%	-25.3%	-25.3%	-30.2%	-31.2%	-26.1%	-26.09%
ROA	19.1%	16.5%	13.7%	-23.6%	-26.3%	-26.0%	-21.6%	-17.8%	-15.9%	-6.9%	-9.3%	-11.7%	-11.0%	-16.4%	-16.7%	-21.4%	-21.7%	-25.8%	-23.2%	-19.3%	-19.28%
ROIC	1.7%	1.5%	1.2%	-1.9%	-1.8%	-1.7%	-2.1%	-1.3%	-1.5%	-41.1%	-1.1%	-1.3%	-1.1%	-1.5%	-1.9%	-2.2%	-1.1%	-1.5%	-3.2%	-2.5%	-2.53%
ROCE	15.1%	14.2%	12.5%	-27.0%	-31.2%	-31.7%	-26.8%	-22.9%	-21.4%	-10.5%	-12.9%	-16.0%	-15.3%	-21.7%	-23.2%	-28.7%	-25.8%	-29.0%	-22.7%	-18.8%	-18.77%
Gross Margin	-67.3%	-9.5%	-171.2%	-213.7%	-412.4%	-1136.2%	57.8%	36.2%	—	90.0%	-101.8%	-109.2%	—	1.0%	-65.5%	—	-71.8%	-67.7%	-33.5%	-3.4%	-3.38%
Operating Margin	-391.6%	-11.3%	-988.6%	-1159.9%	-1940.3%	-21923.5%	-64.5%	-1.4%	—	34.8%	-278.9%	-292.6%	—	-1.8%	-171.6%	—	-148.5%	-179.1%	-89.3%	-11.3%	-11.28%
Net Margin	-386.5%	-11.0%	-1006.8%	-1176.2%	-1856.9%	-18429.2%	-53.1%	-1.1%	—	44.7%	-231.3%	-244.5%	—	-1.1%	-157.2%	—	-119.7%	-151.2%	-84.3%	-9.0%	-8.95%
EBITDA Margin	-375.5%	-10.8%	-954.7%	-1113.9%	-1886.9%	-20949.2%	-59.4%	-1.3%	—	37.2%	-269.4%	-283.2%	—	-1.7%	-166.1%	—	-114.0%	-143.9%	-80.8%	-10.9%	-10.86%
FCF Margin	51.6%	50.0%	45.4%	-38.0%	-38.2%	-1222.3%	-3.8%	-2.1%	-1.7%	-72.9%	-61.6%	-62.7%	-95.1%	-4.0%	-8.5%	-9.1%	-8.2%	-132.1%	-124.9%	-27.9%	-27.91%
OCF Margin	60.3%	59.0%	55.2%	-32.8%	-35.1%	-1137.0%	-3.5%	-2.0%	-1.6%	-70.4%	-58.9%	-60.6%	-93.9%	-4.0%	-8.4%	-9.1%	-8.2%	-131.8%	-124.6%	-27.6%	-27.60%
ROE 3Y Avg	snapshot only																				-22.20%
ROE 5Y Avg	snapshot only																				-23.96%
ROA 3Y Avg	snapshot only																				-17.14%
ROIC Economic	snapshot only																				-16.61%
Cash ROA	snapshot only																				-13.94%
Cash ROIC	snapshot only																				-2.23%
CROIC	snapshot only																				-2.25%
NOPAT Margin	snapshot only																				-31.38%
Pretax Margin	snapshot only																				-33.46%
R&D / Revenue	snapshot only																				20.18%
SGA / Revenue	snapshot only																				5.08%
SBC / Revenue	snapshot only																				3.88%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	20.73	15.38	15.53	-7.44	-7.49	-4.90	-6.79	-10.68	-10.20	-33.14	-25.68	-17.26	-16.71	-9.18	-7.58	-9.05	-12.12	-8.11	-8.04	-11.67	-10.813
P/S Ratio	9.48	6.36	5.30	347.28	382.53	7303.62	35.49	26.10	21.20	13.76	20.61	22.82	19.92	93.39	80.38	118.08	161.00	1801.25	1422.97	393.06	371.623
P/B Ratio	3.40	2.42	2.16	2.25	2.61	1.70	1.92	2.44	2.09	2.70	2.68	2.32	2.06	1.74	1.60	2.48	3.09	2.45	2.52	3.01	2.844
P/FCF	18.36	12.70	11.68	-9.13	-10.02	-5.98	-9.45	-12.27	-12.32	-18.87	-33.47	-36.39	-20.94	-23.25	-9.50	-13.01	-19.52	-13.63	-11.39	-14.08	-14.082
P/OCF	15.70	10.78	9.59	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EV/EBITDA	14.72	9.33	8.57	-4.74	-5.20	-2.49	-3.56	-6.44	-5.23	-17.94	-13.27	-8.40	-7.33	-3.76	-2.83	-5.11	-8.32	-5.28	-5.13	-8.11	-8.113
EV/Revenue	6.95	4.00	3.13	212.89	258.45	3699.73	19.11	17.15	12.39	9.83	13.69	14.01	11.42	46.74	35.42	76.00	119.87	1197.39	907.82	275.04	275.035
EV/EBIT	15.23	9.78	9.15	-4.56	-5.01	-2.40	-3.41	-6.16	-4.97	-16.34	-12.40	-7.94	-6.91	-3.61	-2.72	-4.93	-8.04	-5.11	-4.96	-7.79	-7.792
EV/FCF	13.48	7.99	6.90	-5.60	-6.77	-3.03	-5.09	-8.06	-7.20	-13.47	-22.23	-22.34	-12.01	-11.64	-4.19	-8.37	-14.53	-9.06	-7.27	-9.85	-9.854
Earnings Yield	4.8%	6.5%	6.4%	-13.4%	-13.4%	-20.4%	-14.7%	-9.4%	-9.8%	-3.0%	-3.9%	-5.8%	-6.0%	-10.9%	-13.2%	-11.0%	-8.3%	-12.3%	-12.4%	-8.6%	-8.57%
FCF Yield	5.4%	7.9%	8.6%	-10.9%	-10.0%	-16.7%	-10.6%	-8.1%	-8.1%	-5.3%	-3.0%	-2.7%	-4.8%	-4.3%	-10.5%	-7.7%	-5.1%	-7.3%	-8.8%	-7.1%	-7.10%
Price/Tangible Book	snapshot only																				3.014
Shareholder Yield	snapshot only																				0.00%

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	26.18	20.17	19.88	17.57	12.81	15.30	13.00	14.00	15.83	17.54	17.81	15.73	21.64	22.07	15.64	16.61	16.22	13.32	17.96	17.85	17.847
Quick Ratio	26.18	20.17	19.88	17.57	12.81	15.30	13.00	14.00	15.83	17.54	17.81	15.73	21.64	22.07	15.64	16.61	16.22	13.32	17.96	17.85	17.847
Debt/Equity	0.08	0.09	0.11	0.12	0.12	0.13	0.13	0.14	0.14	0.13	0.11	0.12	0.12	0.12	0.12	0.13	0.21	0.21	0.43	0.45	0.449
Net Debt/Equity	-0.90	-0.90	-0.88	-0.87	-0.85	-0.84	-0.89	-0.84	-0.87	-0.77	-0.90	-0.89	-0.88	-0.87	-0.89	-0.88	-0.79	-0.82	-0.91	-0.90	-0.905
Debt/Assets	0.07	0.08	0.09	0.10	0.10	0.11	0.11	0.11	0.12	0.11	0.10	0.10	0.10	0.10	0.10	0.11	0.18	0.17	0.29	0.30	0.296
Debt/EBITDA	0.48	0.57	0.72	-0.40	-0.37	-0.38	-0.45	-0.54	-0.60	-1.18	-0.84	-0.69	-0.73	-0.50	-0.48	-0.40	-0.76	-0.66	-1.39	-1.73	-1.726
Net Debt/EBITDA	-5.34	-5.50	-5.95	2.99	2.50	2.42	3.05	3.36	3.72	7.18	6.71	5.28	5.46	3.76	3.59	2.83	2.86	2.66	2.91	3.48	3.481
Interest Coverage	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity Multiplier	1.12	1.15	1.16	1.18	1.20	1.20	1.21	1.21	1.21	1.18	1.17	1.18	1.16	1.16	1.18	1.19	1.17	1.18	1.50	1.52	1.518
Cash Ratio	snapshot only																				17.791
Cash to Debt	snapshot only																				3.017
FCF to Debt	snapshot only																				-0.477
Defensive Interval	snapshot only																				2644.1 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.42	0.40	0.40	0.01	0.01	0.00	0.04	0.07	0.08	0.17	0.12	0.09	0.09	0.02	0.02	0.02	0.02	0.00	0.00	0.01	0.006
Inventory Turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables Turnover	6878.65	4069.63	6236.23	125.59	132.63	2.86	1402.21	4.86	6939.02	3.70	—	5.74	—	0.32	—	—	—	0.21	—	—	—
Payables Turnover	10.40	17.09	10.70	12.54	11.27	5.22	3.37	5.02	4.02	3.97	4.54	8.22	6.71	4.54	8.51	11.85	12.23	17.54	16.43	20.79	20.786
DSO	0	0	0	3	3	128	0	75	0	99	0	64	0	1140	0	0	0	1743	0	0	0.0 days
DIO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.0 days
DPO	35	21	34	29	32	70	108	73	91	92	80	44	54	80	43	31	30	21	22	18	17.6 days
Cash Conversion Cycle	-35	-21	-34	-26	-30	58	-108	2	-91	7	-80	19	-54	1060	-43	-31	-30	1722	-22	-18	-17.6 days
Fixed Asset Turnover	snapshot only																				0.057
Cash Velocity	snapshot only																				0.006
Capital Intensity	snapshot only																				197.937

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	10.6%	1269.7%	1194.8%	-98.5%	-98.5%	-100.0%	-89.0%	11.5%	11.8%	847.6%	1.7%	18.2%	18.2%	-90.3%	-86.6%	-82.2%	-81.7%	-92.7%	-91.2%	-62.7%	-62.66%
Net Income	2.9%	2.1%	1.8%	-2.4%	-2.7%	-2.7%	-2.7%	34.3%	48.1%	76.4%	58.6%	36.1%	32.2%	-1.4%	-77.6%	-76.0%	-1.0%	-58.8%	-47.4%	3.6%	3.56%
EPS	2.8%	2.0%	1.8%	-2.5%	-2.6%	-2.7%	-2.6%	35.6%	49.0%	77.2%	60.1%	40.5%	36.9%	-1.3%	-69.0%	-71.7%	-90.3%	-50.9%	-31.9%	13.0%	13.00%
FCF	3.8%	2.8%	2.3%	-2.0%	-2.1%	-2.2%	-1.9%	29.9%	42.5%	49.4%	55.8%	65.2%	34.6%	46.4%	-84.8%	-1.6%	-58.5%	-1.4%	-30.3%	-14.8%	-14.81%
EBITDA	2.9%	2.1%	1.9%	-2.3%	-2.6%	-2.7%	-2.6%	25.6%	39.2%	68.8%	48.2%	26.0%	22.3%	-1.2%	-63.2%	-59.2%	-69.1%	-32.8%	-24.8%	14.9%	14.90%
Op. Income	2.7%	2.1%	1.8%	-2.4%	-2.7%	-2.8%	-2.8%	25.3%	38.4%	66.9%	46.8%	25.1%	21.5%	-1.1%	-58.9%	-55.8%	-72.8%	-42.4%	-36.3%	3.7%	3.73%
OCF Growth	snapshot only																				-13.80%
Asset Growth	snapshot only																				30.60%
Equity Growth	snapshot only																				2.07%
Debt Growth	snapshot only																				2.64%
Shares Change	snapshot only																				10.85%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	1.9%	5.6%	6.6%	1.2%	-60.3%	-88.5%	-29.8%	-16.2%	30.0%	7.0%	6.1%	-39.3%	-39.4%	-66.0%	-65.9%	38.3%	40.2%	81.8%	-68.2%	-57.1%	-57.14%
Revenue 5Y	—	2.3%	1.8%	9.5%	3.9%	-59.7%	20.4%	35.6%	36.9%	1.6%	1.6%	1.7%	-1.1%	-34.1%	-34.0%	-34.1%	-13.8%	29.5%	33.3%	-56.9%	-56.90%
EPS 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS 5Y	—	62.8%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 5Y	—	85.7%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Gross Profit 3Y	—	—	—	—	—	—	—	-18.5%	—	—	—	-58.8%	-56.6%	—	—	—	—	—	—	—	—
Gross Profit 5Y	—	—	—	—	—	—	—	—	—	—	—	—	1.0%	—	—	—	—	—	—	—	—
Op. Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Op. Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Assets 3Y	75.9%	77.9%	73.6%	70.8%	48.4%	28.1%	30.6%	28.0%	12.0%	6.8%	7.6%	-6.9%	-7.2%	-6.6%	-6.0%	-6.3%	-1.6%	0.3%	6.7%	6.5%	6.46%
Assets 5Y	—	51.5%	51.9%	51.9%	52.8%	52.6%	43.1%	44.1%	32.1%	35.5%	37.4%	36.5%	25.6%	16.0%	16.5%	14.2%	8.6%	4.4%	6.8%	-1.8%	-1.78%
Equity 3Y	81.9%	82.9%	80.8%	78.5%	48.9%	25.9%	27.9%	25.9%	8.8%	4.2%	4.9%	-8.7%	-8.3%	-7.0%	-6.6%	-6.5%	-0.7%	0.8%	-0.7%	-1.3%	-1.29%
Book Value 3Y	55.2%	60.4%	58.7%	57.4%	34.6%	15.4%	17.4%	15.7%	4.3%	-0.8%	1.9%	-10.3%	-11.6%	-10.3%	-9.9%	-10.0%	-5.7%	-3.7%	-7.1%	-7.6%	-7.63%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.62	0.46	0.46	0.15	0.10	0.06	0.11	0.01	0.02	0.10	0.09	0.00	0.06	0.13	0.17	0.27	0.04	0.01	0.00	0.82	0.821
Earnings Stability	0.30	0.07	0.04	0.03	0.07	0.07	0.04	0.13	0.14	0.04	0.04	0.15	0.15	0.15	0.17	0.35	0.19	0.17	0.20	0.29	0.287
Margin Stability	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Rev. Growth Consistency	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Earn. Growth Consistency	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.500
FCF Positive Streak	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earnings Persistence	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.50	0.50	0.50	0.50	0.86	0.87	0.50	0.50	0.50	0.50	0.50	0.81	0.99	0.986
Earnings Smoothness	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE Trend	0.25	0.23	0.22	-0.40	-0.35	-0.32	-0.24	-0.16	-0.11	0.01	-0.03	0.13	0.15	0.02	-0.02	-0.09	-0.09	-0.17	-0.16	-0.05	-0.055
Gross Margin Trend	1.70	185.71	152.40	-15.87	-16.29	-67.12	151.19	7.51	8.34	126.19	0.21	7.81	8.59	123.28	-2.59	-2.41	-3.86	-84.76	-66.36	-14.38	-14.379
FCF Margin Trend	1.55	178.94	202.77	-38.38	-37.34	-1044.04	198.40	16.61	17.10	610.18	1.04	19.45	18.99	607.51	-6.28	-7.70	-6.91	-129.76	-120.40	-23.06	-23.060
Sustainable Growth Rate	21.4%	18.6%	15.4%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Internal Growth Rate	23.7%	19.7%	15.8%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.32	1.43	1.62	0.70	0.69	0.76	0.67	0.82	0.79	1.70	0.73	0.46	0.79	0.39	0.79	0.69	0.62	0.59	0.70	0.82	0.819
FCF/OCF	0.86	0.85	0.82	1.16	1.09	1.08	1.07	1.05	1.05	1.04	1.04	1.04	1.01	1.01	1.00	1.00	1.00	1.00	1.00	1.01	1.011
FCF/Net Income	snapshot only																				0.829
CapEx/Revenue	8.7%	8.9%	9.9%	5.3%	3.0%	85.3%	24.8%	11.1%	8.8%	2.6%	2.6%	2.1%	1.2%	5.3%	3.8%	2.2%	1.8%	34.9%	37.7%	31.5%	31.48%
CapEx/Depreciation	snapshot only																				0.226
Accruals Ratio	-0.06	-0.07	-0.08	-0.07	-0.08	-0.06	-0.07	-0.03	-0.03	0.05	-0.02	-0.06	-0.02	-0.10	-0.03	-0.07	-0.08	-0.10	-0.07	-0.03	-0.035
Sloan Accruals	snapshot only																				0.252
Cash Flow Adequacy	snapshot only																				-87.662

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Payout Ratio	0.0%	0.0%	0.0%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Payout Ratio	0.0%	0.0%	0.0%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	-7.3%	-4.0%	-0.5%	-0.6%	-0.4%	-0.4%	-0.2%	-0.6%	-0.7%	-1.2%	-6.1%	-7.0%	-8.1%	-8.9%	-1.0%	-0.7%	-5.1%	-8.6%	-21.6%	-18.9%	-18.90%
Total Shareholder Return	-7.3%	-4.0%	-0.5%	-0.6%	-0.4%	-0.4%	-0.2%	-0.6%	-0.7%	-1.2%	-6.1%	-7.0%	-8.1%	-8.9%	-1.0%	-0.7%	-5.1%	-8.6%	-21.6%	-18.9%	-18.90%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.99	0.98	0.97	1.02	1.02	1.00	1.00	0.98	0.98	1.02	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.007
Interest Burden (EBT/EBIT)	1.01	1.03	1.03	0.98	0.97	0.97	0.94	0.89	0.85	0.68	0.72	0.74	0.71	0.78	0.80	0.84	0.88	0.94	0.96	0.95	0.948
EBIT Margin	0.46	0.41	0.34	-46.73	-51.57	-1543.95	-5.60	-2.78	-2.49	-0.60	-1.10	-1.76	-1.65	-12.95	-13.04	-15.40	-14.91	-234.37	-182.88	-35.30	-35.298
Asset Turnover	0.42	0.40	0.40	0.01	0.01	0.00	0.04	0.07	0.08	0.17	0.12	0.09	0.09	0.02	0.02	0.02	0.02	0.00	0.00	0.01	0.006
Equity Multiplier	1.12	1.13	1.13	1.14	1.16	1.17	1.18	1.19	1.21	1.19	1.19	1.19	1.18	1.17	1.18	1.18	1.17	1.17	1.34	1.35	1.354

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$5.40	$4.93	$4.04	$-8.17	$-8.73	$-8.30	$-6.66	$-5.26	$-4.45	$-1.89	$-2.65	$-3.13	$-2.81	$-4.29	$-4.49	$-5.37	$-5.35	$-6.47	$-5.92	$-4.67	$-4.67
Book Value/Share	$32.94	$31.30	$29.12	$26.97	$25.04	$23.94	$23.58	$22.96	$21.76	$23.15	$25.48	$23.33	$22.76	$22.61	$21.28	$19.65	$20.98	$21.37	$18.89	$18.10	$18.10
Tangible Book/Share	$32.94	$31.30	$29.12	$26.97	$25.04	$23.94	$23.58	$22.96	$21.76	$23.15	$25.48	$23.33	$22.76	$22.61	$21.28	$19.65	$20.98	$21.37	$18.89	$18.10	$18.10
Revenue/Share	$11.81	$11.92	$11.85	$0.17	$0.17	$0.01	$1.27	$2.15	$2.14	$4.55	$3.31	$2.37	$2.36	$0.42	$0.42	$0.41	$0.40	$0.03	$0.03	$0.14	$0.14
FCF/Share	$6.10	$5.97	$5.37	$-6.65	$-6.52	$-6.80	$-4.79	$-4.57	$-3.68	$-3.32	$-2.04	$-1.48	$-2.24	$-1.69	$-3.58	$-3.74	$-3.32	$-3.85	$-4.18	$-3.87	$-3.87
OCF/Share	$7.13	$7.03	$6.54	$-5.74	$-6.00	$-6.33	$-4.47	$-4.34	$-3.50	$-3.20	$-1.95	$-1.43	$-2.22	$-1.67	$-3.57	$-3.73	$-3.31	$-3.84	$-4.16	$-3.83	$-3.83
Cash/Share	$32.47	$31.04	$28.81	$26.64	$24.30	$23.17	$23.94	$22.36	$21.91	$20.83	$25.77	$23.57	$22.71	$22.28	$21.59	$19.81	$20.98	$21.97	$25.42	$24.50	$24.50
EBITDA/Share	$5.58	$5.11	$4.32	$-7.86	$-8.49	$-8.28	$-6.84	$-5.72	$-5.07	$-2.49	$-3.41	$-3.95	$-3.67	$-5.23	$-5.30	$-6.13	$-5.80	$-6.61	$-5.92	$-4.70	$-4.70
Debt/Share	$2.69	$2.94	$3.10	$3.13	$3.10	$3.12	$3.05	$3.10	$3.04	$2.93	$2.87	$2.72	$2.67	$2.62	$2.55	$2.47	$4.42	$4.39	$8.20	$8.12	$8.12
Net Debt/Share	$-29.78	$-28.10	$-25.71	$-23.52	$-21.20	$-20.06	$-20.88	$-19.26	$-18.87	$-17.89	$-22.90	$-20.85	$-20.04	$-19.66	$-19.04	$-17.33	$-16.56	$-17.58	$-17.22	$-16.38	$-16.38

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.781
Altman Z-Prime	snapshot only																				7.796
Piotroski F-Score	7	7	5	2	1	1	2	4	4	5	5	5	5	4	2	2	1	1	3	3	3
Beneish M-Score	1.37	38.57	-3.24	1407.56	-2.78	-334.49	339.91	81.10	—	29062.96	-31.24	-28.39	—	-4.60	-1.47	—	—	-12.13	-1.50	—	—
Ohlson O-Score	snapshot only																				-7.871
ROIC (Greenblatt)	snapshot only																				-19.12%
Net-Net WC	snapshot only																				$15.21
EVA	snapshot only																				$-436769630.00

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				BBB+
Credit Score	94.66	94.60	94.68	75.72	75.62	76.84	76.00	75.96	76.21	76.57	76.21	76.30	76.10	76.06	76.05	76.16	75.01	74.87	58.09	62.19	62.191
Credit Grade	snapshot only																				8
Credit Trend	snapshot only																				-13.972
Implied Spread (bps)	snapshot only																				225.000
Industry Credit Rank	snapshot only																				57
Sector Credit Rank	snapshot only																				54

CRSP NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet